John D. Shire was featured in the Bloomberg BNA article, "Enforcement May Stymie Health-Care Deal Activity in 2016." Full text can be found in the January 4, 2016, issue, but a synopsis is below.
Fox Rothschild's John Shire told Bloomberg BNA in an interview that although mergers and acquisitions in the health-care sector will continue to prosper in 2016, ongoing enforcement activity may slow deal growth.
The agencies and entities responsible for this enforcement activity, "could serve as a roadblock in future" merger and acquisition transactions, according to Shire.
Shire added that the health-care industry is consolidating at a rapid pace due to low lending costs, the search for efficiencies and the Affordable Care Act.
Shire also expects consolidations to continue in the life-sciences, biotechnology sectors and among companies that make brand-name and generic products, as they all look for efficiencies.
Hospitals and health-services companies will continue on a strong M&A pace due to regulations that are creating incentives for alignments, he added.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
